TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34808440

Group type: EXPERIMENTAL
Intervention: Low-impact moderate-intensity exercise program
Number of subjects: 124

Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 124
Study: 32237884

Group type: EXPERIMENTAL
Intervention: Therapist-guided exposure in CBT
Number of subjects: 197
Study: 32856189

Group type: EXPERIMENTAL
Intervention: Lean-seafood intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-seafood intervention
Number of subjects: 20
Study: 32144133

Group type: EXPERIMENTAL
Intervention: gefitinib + fulvestrant (G+F)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: erlotinib + fulvestrant (E+F)
Number of subjects: 204

Group type: COMPARATOR
Intervention: gefitinib
Number of subjects: 204

Group type: COMPARATOR
Intervention: erlotinib
Number of subjects: 204
Study: 35842107

Group type: EXPERIMENTAL
Intervention: Increased n-3 EPA + DHA with low n-6 LA (H3L6)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual US dietary content of n-3 and n-6 fatty acids (Control)
Number of subjects: 122
Study: 34138788

Group type: COMPARATOR
Intervention: ACLR
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ALSA
Number of subjects: 120
Study: 32294318

Group type: EXPERIMENTAL
Intervention: No Appointment but Reminder
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Appointment & Reminder
Number of subjects: 651

Group type: COMPARATOR
Intervention: No Appointment & No Reminder (control arm)
Number of subjects: 651
Study: 35171190

Group type: EXPERIMENTAL
Intervention: Perilla seed oil (PO)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Perilla seed oil with nobiletin-rich ponkan powder (POPP)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: POPP
Number of subjects: 49
Study: 34163193

Group type: EXPERIMENTAL
Intervention: Fufang Zhenzhu Tiaozhi capsule (FTZ) with basic treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo with basic treatment
Number of subjects: 160
Study: 33012443

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 36053020

Group type: EXPERIMENTAL
Intervention: TRAUMACEM V+ Injectable Bone Cement augmentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No augmentation
Number of subjects: 0
Study: 33223395

Group type: EXPERIMENTAL
Intervention: PRN medication prescribed
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: PRN medication administered
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: PRN medication administration
Number of subjects: 242

Group type: COMPARATOR
Intervention: Overall PRN prescribing and administration
Number of subjects: 242
Study: 32237290

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (50 or 70 mg)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 36121045

Group type: EXPERIMENTAL
Intervention: Cerebral Embolic Protection (CEP) during TAVR
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Control group (no CEP) during TAVR
Number of subjects: 3000
Study: 34221018

Group type: EXPERIMENTAL
Intervention: MI Paste® (bleaching and MI Paste®)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (only bleaching)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (MI Paste® and control)
Number of subjects: 45
Study: 32660716

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 60
Study: 34379589

Group type: EXPERIMENTAL
Intervention: Proposed quantization system for heatmap regression
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-resolution heatmaps (previous methods)
Number of subjects: 0
Study: 35776843

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 616381975

Group type: EXPERIMENTAL
Intervention: Real rTMS (1 Hz for 1200 pulses with two boosters)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation (disconnected coil)
Number of subjects: 10
Study: 34291992

Group type: EXPERIMENTAL
Intervention: Smartphone-assisted mindfulness-based smoking cessation intervention with contingency management (SMI-CM)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enhanced standard treatment (EST)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: SMI-CM
Number of subjects: 49
Study: 34931480

Group type: EXPERIMENTAL
Intervention: Low psychosocial burden group (n=231)
Number of subjects: 287

Group type: COMPARATOR
Intervention: High psychosocial burden group (n=56)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Baseline psychosocial variables (SF-36, IPQ-R, UCL)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Week 16 psychosocial variables (SF-36, IPQ-R)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Temporal relationships between psychosocial wellbeing and DAS28-CRP
Number of subjects: 287
Study: 32860737

Group type: EXPERIMENTAL
Intervention: Cenerimod 4 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32483139

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 mcg/kg given 2 minutes before intubation
Number of subjects: 145

Group type: COMPARATOR
Intervention: Fentanyl 2 mcg/kg given 1 minute before intubation
Number of subjects: 145

Group type: COMPARATOR
Intervention: Fentanyl 2 mcg/kg given 3 minutes before intubation
Number of subjects: 145
Study: 36396519

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg for 14 days once daily
Number of subjects: 472

Group type: COMPARATOR
Intervention: Standard of care (no thromboprophylaxis)
Number of subjects: 472
Study: 33032917

Group type: EXPERIMENTAL
Intervention: Informed about the activity tracker
Number of subjects: 235

Group type: COMPARATOR
Intervention: Blinded to the purpose of the activity tracker
Number of subjects: 235
Study: 35667914

Group type: EXPERIMENTAL
Intervention: Single-dose Ad26.COV2.S (5 × 10^10 viral particles)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 5 × 10^10 vp 2-month booster dose
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 6-month booster (5 × 10^10 vp)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 6-month booster (1.25 × 10^10 vp)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Booster doses
Number of subjects: 73
Study: 32514590

Group type: EXPERIMENTAL
Intervention: Transnasal evaporative intra-arrest cooling initiated by emergency medical services (early cooling)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Transnasal evaporative intra-arrest cooling initiated by emergency medical services (early cooling) in patients with shockable rhythm
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cooling started after hospital arrival (control)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cooling started after hospital arrival (control) in patients with shockable rhythm
Number of subjects: 300
Study: 36568722

Group type: EXPERIMENTAL
Intervention: Boswellia and ginger mixture (Memoral: 360 mg Boswellia and 36 mg ginger)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35971135

Group type: EXPERIMENTAL
Intervention: Office-GAP + Texting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Texting only
Number of subjects: 0
Study: 32233251

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (0.5 g diluted in 20 ml normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (10 ml)
Number of subjects: 60
Study: 32829540

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide mixed with dexamethasone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Triple antibiotic paste
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cotton pellet (placebo)
Number of subjects: 120
Study: 34693748

Group type: EXPERIMENTAL
Intervention: Whole Health Team arm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Primary Care Group Education arm
Number of subjects: 0
Study: 32545100

Group type: EXPERIMENTAL
Intervention: Logotherapy intervention
Number of subjects: 18
Study: 35285940

Group type: EXPERIMENTAL
Intervention: Higher BMI in African ancestry patients
Number of subjects: 2854

Group type: EXPERIMENTAL
Intervention: Severe obesity (BMI ≥40) in African ancestry patients
Number of subjects: 2854

Group type: EXPERIMENTAL
Intervention: Higher BMI in estrogen receptor-positive (ER+) African ancestry patients
Number of subjects: 2854

Group type: COMPARATOR
Intervention: Higher BMI in European ancestry patients
Number of subjects: 2854
Study: 34310694

Group type: EXPERIMENTAL
Intervention: Targeting an arterial partial pressure of oxygen of 8 kPa
Number of subjects: 780

Group type: COMPARATOR
Intervention: Targeting an arterial partial pressure of oxygen of 12 kPa
Number of subjects: 780
Study: 32586268

Group type: EXPERIMENTAL
Intervention: HIIT + green tea
Number of subjects: 30

Group type: COMPARATOR
Intervention: HIIT + placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: green tea
Number of subjects: 30
Study: 34728062

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg/day
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 34019711

Group type: EXPERIMENTAL
Intervention: KBP-042 (5, 7.5, 10, 20, 20 (evening), 40 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KBP-042 (5-40 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KBP-042
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32456653

Group type: EXPERIMENTAL
Intervention: TRUST4RD approach for identifying uncertainties in evidence generation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real World Evidence (RWE)
Number of subjects: 0
Study: 34791356

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychoeducation (CBE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 36
Study: 34293413

Group type: EXPERIMENTAL
Intervention: Multicomponent chair-based exercise intervention (16 weeks, twice a week, 60 min)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 52
Study: 32769595

Group type: EXPERIMENTAL
Intervention: Epidural Steroid Injection (ESI)
Number of subjects: 266
Study: 34085136

Group type: EXPERIMENTAL
Intervention: Active device (Equistasi®)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 24
Study: 33919500

Group type: EXPERIMENTAL
Intervention: Life skills
Number of subjects: 1745

Group type: EXPERIMENTAL
Intervention: Gender differences in life skills
Number of subjects: 1745
Study: 35986353

Group type: EXPERIMENTAL
Intervention: 500 mg Tribulus terrestris supplement twice daily for 2 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo capsules twice daily for 2 weeks
Number of subjects: 34
Study: 34288094

Group type: EXPERIMENTAL
Intervention: LiRIS 400 mg
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 33041071

Group type: EXPERIMENTAL
Intervention: ICG‐99mTc‐nanocolloid (fluorescence imaging group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 99mTc‐nanocolloid with blue dye (standard group)
Number of subjects: 48
Study: 32515119

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 10 mg/kg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 33070045

Group type: EXPERIMENTAL
Intervention: Bright white light (BWL)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Dim red light (DRL)
Number of subjects: 77
Study: 34864678

Group type: EXPERIMENTAL
Intervention: Olfactory Training (OT), performed twice a day for 4 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control training condition, performed twice a day for 4 months
Number of subjects: 38
Study: 32988369

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam (group M)
Number of subjects: 0
Study: 33387346

Group type: EXPERIMENTAL
Intervention: White Mineral Trioxide Aggregate (WMTA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biodentine™ (BD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (positive controls with no treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (negative controls with normal saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 33154058

Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Strengthening approach
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Motor control-focused approach
Number of subjects: 123

Group type: COMPARATOR
Intervention: All intervention groups
Number of subjects: 123
Study: 36147397

Group type: EXPERIMENTAL
Intervention: Single visit root canal therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multiple visit root canal therapy
Number of subjects: 60
Study: 35379296

Group type: EXPERIMENTAL
Intervention: Sequential multiple ascending doses of solnatide
Number of subjects: 16
Study: 34155991

Group type: EXPERIMENTAL
Intervention: Modified combined program of physical therapy and ergotherapy (including PNF, balance training, upright posture correction, constraint‐induced movement therapy, dual task activities, stimulation of the affected side in daily activities, targeted therapy) for 3 months
Number of subjects: 58

Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation (PNF), balance training, ergotherapeutic intervention, and exercises improving fine motor skills
Number of subjects: 58
Study: 35876893

Group type: EXPERIMENTAL
Intervention: Low-speed PRF + OFD
Number of subjects: 22

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 22
Study: 33845853

Group type: EXPERIMENTAL
Intervention: Wearable activity tracker (Fitbit Flex) combined with digital behaviour change resources and weekly challenges delivered via Facebook
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 275

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 275
Study: 32381562

Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 2 weeks (Q2W) full maintenance dose
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 4 weeks (Q4W) reduced maintenance dose
Number of subjects: 736

Group type: COMPARATOR
Intervention: Placebo (withdrawal)
Number of subjects: 736
Study: 36070710

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1323

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 1323

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 1323
Study: 34852764

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca compartment block using the supra-inguinal approach (group F)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ultrasound-guided fascia iliaca compartment block using the classical approach (group C)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 33269511

Group type: COMPARATOR
Intervention: Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (TRS‐HFDM)
Number of subjects: 5123
Study: 32052925

Group type: EXPERIMENTAL
Intervention: Test warfarin sodium tablet
Number of subjects: 56

Group type: COMPARATOR
Intervention: Reference product Coumadin (2.5 mg)
Number of subjects: 56
Study: 35108378

Group type: EXPERIMENTAL
Intervention: High Carbohydrate, High Starch (HC-Starch) diet (57% carbohydrate and 25% fat, including 20% refined grains)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High Carbohydrate, High Sugar (HC-Sugar) diet (57% carbohydrate and 25% fat, including 20% sugar)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Very-Low-Carbohydrate (VLC) diet (5% carbohydrate and 77% fat)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High Carbohydrate groups (HC-Starch and HC-Sugar)
Number of subjects: 64
Study: 33792551

Group type: EXPERIMENTAL
Intervention: Text Messaging Intervention (TMI) for 6 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Group-based cessation counseling and nicotine patches
Number of subjects: 77
Study: 33730752

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.25 mg/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 32939044

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34048554

Group type: EXPERIMENTAL
Intervention: Delays of ≥3 days to concordant antibiotic treatment
Number of subjects: 1203

Group type: COMPARATOR
Intervention: Delays of 1-2 days to concordant antibiotic treatment
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Delays in appropriate antibiotic treatment
Number of subjects: 1203
Study: 33494103

Group type: EXPERIMENTAL
Intervention: Osstell device
Number of subjects: 80
Study: 34775223

Group type: EXPERIMENTAL
Intervention: Immediate goal‐dose enteral nutrition (IGEN)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Gradual goal‐dose enteral nutrition (GGEN)
Number of subjects: 406
Study: 32080084

Group type: EXPERIMENTAL
Intervention: Ucha‐Shinki‐Hwan (UCHA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 36817812

Group type: EXPERIMENTAL
Intervention: Dracocephalum extract (250 mg, twice daily for one month)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (250 mg starch, twice daily for one month)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Comparison between Dracocephalum and placebo
Number of subjects: 110
Study: 33067692

Group type: EXPERIMENTAL
Intervention: 0.5 Hz electrical stimulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.1 Hz electrical stimulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.6 Hz electrical stimulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Stimulation at bladder dome
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Stimulation at trigone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Stimulation at proximal urethra (men only)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Stimulation at distal urethra
Number of subjects: 90
Study: 36890047

Group type: EXPERIMENTAL
Intervention: Watchman 2.5 device
Number of subjects: 2258
Study: 32721239

Group type: EXPERIMENTAL
Intervention: Shaved cartilage plus platelet-rich fibrin (SC+PRF)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Diced cartilage (DC)
Number of subjects: 200
Study: 35276337

Group type: EXPERIMENTAL
Intervention: Opt-out referral approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Opt-in referral approach
Number of subjects: 0
Study: 34547006

Group type: EXPERIMENTAL
Intervention: Black rice extract (1 g/d)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 1 g/d)
Number of subjects: 105
Study: 35536441

Group type: EXPERIMENTAL
Intervention: Chlormethine gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlormethine ointment
Number of subjects: 0
Study: 33213488

Group type: EXPERIMENTAL
Intervention: Tibial nerve electrostimulation (TNES)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Parasacral electrostimulation (PSES)
Number of subjects: 44
Study: 34862191

Group type: EXPERIMENTAL
Intervention: Tactile stimulation during PPV
Number of subjects: 40

Group type: COMPARATOR
Intervention: No tactile stimulation (immediately prior to stimulation)
Number of subjects: 40
Study: 35752028

Group type: EXPERIMENTAL
Intervention: Predictive model based on liquid biopsy for NSCLC
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Nomogram parameters including gene mutation type, differentiation degree, CTC content, and brain metastasis
Number of subjects: 500
Study: 33723806

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lemborexant 25 mg
Number of subjects: 17
Study: 32149456

Group type: EXPERIMENTAL
Intervention: Similar Age Same Gender (SASG)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Similar Age Mixed Gender (SAMG)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Mixed Age Mixed Gender (MAMG)
Number of subjects: 485
Study: 34973100

Group type: EXPERIMENTAL
Intervention: Critically reflective dialogue
Number of subjects: 75

Group type: COMPARATOR
Intervention: Social Determinants of Health (SDoH) discussion
Number of subjects: 75
Study: 33427160

Group type: EXPERIMENTAL
Intervention: Intervention (INFANT program)
Number of subjects: 492
Study: 32887793

Group type: EXPERIMENTAL
Intervention: DHA + AA supplementation (200 mg DHA + 200 mg AA daily for 180 days)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo (400 mg corn oil)
Number of subjects: 377
Study: 35753841

Group type: EXPERIMENTAL
Intervention: Moderna COVID-19 Vaccine (mRNA-1273)
Number of subjects: 30000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30000
Study: 33457089

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 1420
Study: 36351740

Group type: EXPERIMENTAL
Intervention: Single-orifice catheters
Number of subjects: 182

Group type: COMPARATOR
Intervention: Multiorifice catheters
Number of subjects: 182
Study: 33883880

Group type: EXPERIMENTAL
Intervention: Rapid intravenous injection of omeprazole (group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continuous micropump infusion of omeprazole (group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 120
Study: 35105621

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 318
Study: 33888532

Group type: EXPERIMENTAL
Intervention: Supervised exercise training (spinning) three times per week for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study: 33171172

Group type: EXPERIMENTAL
Intervention: Skeletonized LIMA
Number of subjects: 62

Group type: COMPARATOR
Intervention: Pedicled LIMA
Number of subjects: 62
Study: 33188069

Group type: EXPERIMENTAL
Intervention: Dynamic signals in the anterior prefrontal cortex (aPFC) during forced-choice trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interregional negative coupling between the prefrontal region and the ventral striatum (VS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced ventral striatal activity during consumption of liquid rewards
Number of subjects: 0
Study: 35945859

Group type: EXPERIMENTAL
Intervention: Calcium gluconate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 60
Study: 33607806

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway-supreme (LM-S)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 100
Study: 32623487

Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg IV
Number of subjects: 141

Group type: COMPARATOR
Intervention: No further active treatment
Number of subjects: 141